| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.035 | 0.4 |